Akio Murase

403 total citations
11 papers, 345 citations indexed

About

Akio Murase is a scholar working on Pharmacology, Organic Chemistry and Molecular Biology. According to data from OpenAlex, Akio Murase has authored 11 papers receiving a total of 345 indexed citations (citations by other indexed papers that have themselves been cited), including 9 papers in Pharmacology, 6 papers in Organic Chemistry and 4 papers in Molecular Biology. Recurrent topics in Akio Murase's work include Inflammatory mediators and NSAID effects (9 papers), Receptor Mechanisms and Signaling (4 papers) and Eicosanoids and Hypertension Pharmacology (3 papers). Akio Murase is often cited by papers focused on Inflammatory mediators and NSAID effects (9 papers), Receptor Mechanisms and Signaling (4 papers) and Eicosanoids and Hypertension Pharmacology (3 papers). Akio Murase collaborates with scholars based in Japan and United States. Akio Murase's co-authors include Junji Takada, Kazunari Nakao, Takako Okumura, Kana Taniguchi, Yoko Murata, Hiroko Tonai‐Kachi, Hiroyuki Ohshiro, Tomoki Kato, Yoshiyuki Okumura and Yasuhito Taniguchi and has published in prestigious journals such as Journal of Pharmacology and Experimental Therapeutics, British Journal of Pharmacology and Biochemical Pharmacology.

In The Last Decade

Akio Murase

11 papers receiving 323 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Akio Murase Japan 8 187 88 82 81 80 11 345
Takehiro Ochi Japan 12 144 0.8× 86 1.0× 89 1.1× 140 1.7× 94 1.2× 28 414
Takako Okumura Japan 10 150 0.8× 107 1.2× 46 0.6× 56 0.7× 34 0.4× 14 324
Tohru Miyazawa Japan 8 240 1.3× 95 1.1× 96 1.2× 76 0.9× 51 0.6× 13 533
R. G. Hill United Kingdom 3 231 1.2× 58 0.7× 39 0.5× 52 0.6× 67 0.8× 6 351
Hideki Ukawa Japan 12 345 1.8× 30 0.3× 132 1.6× 169 2.1× 88 1.1× 18 631
M. J. Andrews United Kingdom 7 306 1.6× 53 0.6× 109 1.3× 36 0.4× 24 0.3× 9 446
Hideto Miyazaki Japan 10 107 0.6× 16 0.2× 140 1.7× 42 0.5× 54 0.7× 24 365
R Alvarez United States 8 97 0.5× 45 0.5× 261 3.2× 55 0.7× 78 1.0× 17 369
P. Pradelles France 9 124 0.7× 16 0.2× 207 2.5× 60 0.7× 34 0.4× 16 466
Yasunobu Ishihara Japan 12 52 0.3× 55 0.6× 265 3.2× 52 0.6× 103 1.3× 30 545

Countries citing papers authored by Akio Murase

Since Specialization
Citations

This map shows the geographic impact of Akio Murase's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Akio Murase with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Akio Murase more than expected).

Fields of papers citing papers by Akio Murase

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Akio Murase. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Akio Murase. The network helps show where Akio Murase may publish in the future.

Co-authorship network of co-authors of Akio Murase

This figure shows the co-authorship network connecting the top 25 collaborators of Akio Murase. A scholar is included among the top collaborators of Akio Murase based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Akio Murase. Akio Murase is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

11 of 11 papers shown
1.
Murase, Akio, et al.. (2014). Design, synthesis and structure–activity relationship studies of novel and diverse cyclooxygenase-2 inhibitors as anti-inflammatory drugs. Journal of Enzyme Inhibition and Medicinal Chemistry. 29(6). 846–867. 7 indexed citations
2.
Murase, Akio, et al.. (2012). Novel acid-type cyclooxygenase-2 inhibitors: Design, synthesis, and structure–activity relationship for anti-inflammatory drug. European Journal of Medicinal Chemistry. 50. 179–195. 39 indexed citations
4.
Murase, Akio, Kazunari Nakao, & Junji Takada. (2008). Characterization of Binding Affinity of CJ-023,423 for Human Prostanoid EP<sub>4</sub> Receptor. Pharmacology. 82(1). 10–14. 3 indexed citations
5.
Okumura, Takako, Yoko Murata, Kana Taniguchi, Akio Murase, & Aisuke Nii. (2008). Effects of the selective EP4 antagonist, CJ-023,423 on chronic inflammation and bone destruction in rat adjuvant-induced arthritis. Journal of Pharmacy and Pharmacology. 60(6). 723–730. 24 indexed citations
6.
Murase, Akio, et al.. (2007). Effect of prostanoid EP4 receptor antagonist, CJ-042,794, in rat models of pain and inflammation. European Journal of Pharmacology. 580(1-2). 116–121. 48 indexed citations
7.
Murase, Akio, Yasuhito Taniguchi, Hiroko Tonai‐Kachi, Kazunari Nakao, & Junji Takada. (2007). In vitro pharmacological characterization of CJ-042794, a novel, potent, and selective prostaglandin EP4 receptor antagonist. Life Sciences. 82(3-4). 226–232. 41 indexed citations
8.
Nakao, Kazunari, Akio Murase, Hiroyuki Ohshiro, et al.. (2007). CJ-023,423, a Novel, Potent and Selective Prostaglandin EP4 Receptor Antagonist with Antihyperalgesic Properties. Journal of Pharmacology and Experimental Therapeutics. 322(2). 686–694. 99 indexed citations
9.
Okumura, Takako, Yoko Murata, Tomomi Matsuura, et al.. (2006). Pharmacological separation between peripheral and central functions of cyclooxygenase-2 with CIAA, a novel cyclooxygenase-2 inhibitor. European Journal of Pharmacology. 539(1-2). 125–130. 10 indexed citations
10.
Nagahisa, Atsushi, et al.. (1993). Non-specific activity of in models of pain and inflammation. Regulatory Peptides. 46(1-2). 433–436. 3 indexed citations
11.
Nagahisa, Atsushi, et al.. (1992). Non‐specific activity of (±)‐CP‐96,345 in models of pain and inflammation. British Journal of Pharmacology. 107(2). 273–275. 48 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026